Format

Send to

Choose Destination
See comment in PubMed Commons below
ACP J Club. 2007 Nov-Dec;147(3):67.

Rosiglitazone increased heart failure but did not differ from metformin plus sulfonylurea for other CV outcomes at interim analysis.

Author information

1
Stanford University School of Medicine, Stanford, California, USA.
PMID:
17975869
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for American College of Physicians-American Society of Internal Medicine
    Loading ...
    Support Center